ClinicalTrials.Veeva

Menu

Concurrent OCT and FFR-guided PCI in CAD (OPTICARE-CAD)

K

Korea University

Status

Enrolling

Conditions

Coronary Artery Disease
Atheroscleroses, Coronary
Image

Treatments

Diagnostic Test: optical coherence tomography and fractional flow reserve
Diagnostic Test: Coronary angiography

Study type

Interventional

Funder types

Other

Identifiers

NCT06182683
OPTICARE-CAD_v1

Details and patient eligibility

About

The present study is a prospective randomized clinical trial aimed to compare the therapeutic strategy of angiography-guided versus concurrent OCT/FFR-guided intervention in patients with coronary artery disease.

Full description

Most previous clinical trials have assessed various interventional strategies guided by intravascular imaging (intravascular imaging-guided PCI), fractional flow reserve (FFR-guided PCI), or conventional angiography (angiography-guided PCI) to compare differences in treatment outcomes. Until now, it remains unclear whether optimizing procedures based on both intravascular imaging and fractional flow reserve indices would lead to improved treatment outcomes compared to PCI guided solely by conventional angiography. Moreover, there are no studies comparing a treatment strategy that combines optical coherence tomography (OCT) and FFR to angiography-guided procedures. Hence, this study aims to compare the clinical effectiveness and therapeutic impact of concurrent guidance using FFR and OCT in patients undergoing coronary artery stent implantation, as compared to procedures guided solely by conventional angiography.

Enrollment

700 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age greater than 19 years old
  2. Patients undergoing coronary stent implantation for stable angina or acute coronary syndrome
  3. Patients provided on informed consent

Exclusion criteria

  1. Individuals with a history of increased bleeding tendencies or hematologic disorders
  2. Presented with refractory cardiogenic shock
  3. Individuals with a history of stent thrombosis
  4. Expected life expectancy of less than 1 year
  5. Left ventricular ejection fraction (LVEF) ≥ 20%
  6. Women who are breastfeeding, pregnant, or planning to become pregnant
  7. Deemed unsuitable for participation by the investigator
  8. Patients unwilling to participate in the clinical trial

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

700 participants in 2 patient groups

Angiography-guided PCI group
Active Comparator group
Description:
This group of patients are intended to undergo PCI with conventional angiography-guidance. Procedural optimization determined by angiographic assessment.
Treatment:
Diagnostic Test: Coronary angiography
Concurrent OCT/FFR-guided PCI group
Experimental group
Description:
This group of patients are intended to undergo PCI with concurrent OCT/FFR-guidance. Procedural optimization determined by OCT and FFR assessment.
Treatment:
Diagnostic Test: optical coherence tomography and fractional flow reserve
Diagnostic Test: Coronary angiography

Trial contacts and locations

1

Loading...

Central trial contact

Dong Oh Kang, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems